Mercaptopurine can cause developmental toxicity according to state or federal government labeling requirements. An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. It is grouped under the following drug class(es): Antineoplastic agents, Cytotoxics and Immunosuppressants. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include mercaptopurine, 6-Thiopurine, Purixan, Xaluprine, Ismipur and Mern. Its PubChem CID is 667490.
6-Mercaptopurine
| CAS No | 50-44-2 |
|---|---|
| Molecular Formula | C5H4N4S |
| Molecular Weight | 152.18 g/mol |
| Synonyms | 3,7-dihydropurine-6-thione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mercaptopurine can cause developmental toxicity according to state or federal government labeling requirements. An antimetabolite antineoplastic agent with immunosuppressant properties.
The listed CAS number is 50-44-2.
The listed molecular formula is C5H4N4S.
The listed molecular weight is 152.18 g/mol.
3,7-dihydropurine-6-thione.
The source lists mercaptopurine, 6-Thiopurine, Purixan, Xaluprine, Ismipur and Mern.